| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rapt Therapeutics, Inc. (RAPT) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 8 sells. RAPT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 0 | - | - | |
| Dir | 0 | - | - | |
| Other | 0 | - | - | |
| Dir | 0 | - | - | |
| CFO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 | Brockstedt Dirk G.71 | Chief Scientific Officer | Sale+OE | 2,647 | $22.47 | $59,478.09 | -11.8% | -44.2% | +24.0% | |
| Jan 13, 2022 | Ho William75 | Chief Medical Officer | Sell | 3,000 | $30.67 | $92,010.00 | -4.9% | -25.5% | -10.8% | |
| Jan 11, 2022 | Brockstedt Dirk G.71 | Chief Scientific Officer | Sale+OE | 2,648 | $32.16 | $85,159.68 | -11.8% | -33.7% | -24.2% | |
| Jan 5, 2022 | Ho William75 | Chief Medical Officer | Sale+OE | 2,000 | $40.00 | $80,000.00 | -3.2% | -38.9% | -41.1% | |
| Dec 10, 2021 | Brockstedt Dirk G.71 | Chief Scientific Officer | Sale+OE | 2,647 | $30.88 | $81,739.36 | -11.8% | -20.2% | -43.1% | |
| Dec 3, 2021 | Ho William75 | Chief Medical Officer | Sell | 3,000 | $32.26 | $96,780.00 | -5.0% | -35.8% | -41.5% | |
| Nov 11, 2021 | Brockstedt Dirk G.71 | Chief Scientific Officer | Sale+OE | 2,648 | $35.69 | $94,507.12 | -11.8% | -37.5% | -35.6% | |
| Oct 18, 2021 | Robbins Wendye59 | Director | Buy | 500 | $30.70 | $15,350.00 | +5.7% | -21.5% | -27.3% | |
| Oct 13, 2021 | Ho William75 | Chief Medical Officer | Sell | 3,000 | $29.69 | $89,070.00 | -4.8% | +9.3% | -26.3% | |
| Oct 13, 2021 | Robbins Wendye59 | Director | Buy | 400 | $29.69 | $11,876.00 | +4.8% | +9.3% | -26.3% |